248 related articles for article (PubMed ID: 19952744)
21. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
[TBL] [Abstract][Full Text] [Related]
23. Early stage uterine papillary serous carcinoma of the endometrium: effect of adjuvant whole abdominal radiotherapy and pathologic parameters on outcome.
Lim P; Al Kushi A; Gilks B; Wong F; Aquino-Parsons C
Cancer; 2001 Feb; 91(4):752-7. PubMed ID: 11241243
[TBL] [Abstract][Full Text] [Related]
24. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
Geisler JP; Geisler HE; Melton ME; Wiemann MC
Gynecol Oncol; 1999 Sep; 74(3):465-7. PubMed ID: 10479511
[TBL] [Abstract][Full Text] [Related]
25. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
[TBL] [Abstract][Full Text] [Related]
26. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
28. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
29. Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.
Huh WK; Powell M; Leath CA; Straughn JM; Cohn DE; Gold MA; Falkner CA; Carey DE; Herzog T; Fowler JM; Partridge EE; Kilgore LC; Alvarez RD
Gynecol Oncol; 2003 Dec; 91(3):470-5. PubMed ID: 14675664
[TBL] [Abstract][Full Text] [Related]
30. Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma.
Bancher-Todesca D; Neunteufel W; Williams KE; Prainsack D; Breitenecker G; Friedlander ML; Hacker NF
Gynecol Oncol; 1998 Dec; 71(3):344-7. PubMed ID: 9887228
[TBL] [Abstract][Full Text] [Related]
31. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
[TBL] [Abstract][Full Text] [Related]
32. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.
Le TD; Yamada SD; Rutgers JL; DiSaia PJ
Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
[TBL] [Abstract][Full Text] [Related]
34. Clinical management of uterine papillary serous carcinoma.
Roelofsen T; van Ham MA; de Hullu JA; Massuger LF
Expert Rev Anticancer Ther; 2011 Jan; 11(1):71-81. PubMed ID: 21166512
[TBL] [Abstract][Full Text] [Related]
35. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
36. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL
Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145
[TBL] [Abstract][Full Text] [Related]
37. Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma.
Kim A; Schreiber D; Rineer J; Choi K; Rotman M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e639-44. PubMed ID: 21507584
[TBL] [Abstract][Full Text] [Related]
38. Uterine papillary serous carcinoma: a review.
Gehrig PA
Expert Opin Pharmacother; 2007 Apr; 8(6):809-16. PubMed ID: 17425476
[TBL] [Abstract][Full Text] [Related]
39. The role of optimal debulking in advanced stage serous carcinoma of the uterus.
Moller KA; Gehrig PA; Van Le L; Secord AA; Schorge J
Gynecol Oncol; 2004 Jul; 94(1):170-4. PubMed ID: 15262137
[TBL] [Abstract][Full Text] [Related]
40. Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.
Boyraz G; Salman MC; Basaran D; Ozgul N; Turan T; Turkmen O; Kimyon GC; Ozkan NT; Cagan M; Gungor T; Meydanli MM; Gungorduk K; Gulseren V; Sanci M; Yuce K
Int J Gynecol Cancer; 2017 Jan; 27(1):102-108. PubMed ID: 27668395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]